{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:26:49Z","timestamp":1792610809144,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.diagmicrobio.2013.01.023","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T15:15:50Z","timestamp":1363187750000},"page":"69-72","source":"Crossref","is-referenced-by-count":19,"title":["Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens"],"prefix":"10.1016","volume":"76","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/AEM.67.1.22-32.2001","article-title":"Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins","volume":"67","author":"Aminov","year":"2001","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0010","series-title":"The antimicrobic susceptibility test: principles and practices","author":"Barry","year":"1976"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0015","series-title":"Antimicrobial agents: antibacterials and antifungals","author":"Bryskier","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2006.01617.x","article-title":"The contribution of pharmacokinetic-pharmacodynamic modeling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis","volume":"13","author":"Burgess","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0025","series-title":"41st ICAAC, December 16\u201319, 2001. Abst. A-1103. Chicago, IL, USA","article-title":"Characterization of the pharmacodynamics of doxycycline against Streptococcus pneumoniae in a murine thigh-infection model","author":"Christianson","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0030","series-title":"In 41st ICAAC, December 16\u201319, 2001. Abst. A-1104. Chicago, IL USA","article-title":"Magnitude of the 24-h AUC\/MIC required for efficacy of doxycycline against Streptococcus pneumoniae in a murine thigh-infection model","author":"Christianson","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0035","series-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0040","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0045","series-title":"Performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23)","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0050","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.clinthera.2008.11.006","article-title":"Update on antimicrobial susceptibility rates among Gram-negative and Gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007","volume":"30","author":"Dowzicky","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0055","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0","author":"EUCAST","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clinmicnews.2011.08.001","article-title":"Pharmacokinetics-pharmacodynamics: a primer for the clinical microbiologist","volume":"33","author":"Iyer","year":"2011","journal-title":"Clin Microbiol News"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-37923","article-title":"Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"24","author":"Jones","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0070","series-title":"CLSI Rationale Document \u2014 Doxycycline and tetracycline breakpoints for Streptococcus pneumoniae","author":"Jorgensen","year":"2013"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0075","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/AAC.00134-09","article-title":"Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2013.01.023_bb0080","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2710.2009.01073.x","article-title":"Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia","volume":"35","author":"Mokabberi","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0090","series-title":"Performance standards for antimicrobial disc susceptibility tests: Vol. 1 No. 6","author":"National Committee for Clinical Laboratory Standards","year":"1981"},{"key":"10.1016\/j.diagmicrobio.2013.01.023_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/AAC.33.4.434","article-title":"Effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline","volume":"33","author":"Nguyen","year":"1989","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931300062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931300062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T04:27:03Z","timestamp":1539836823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931300062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S073288931300062X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.01.023","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}